Skip to content
NewsBlazeIN – Lifestyle
Author:
Duality Biotherapeutics, Inc.
DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio’s DUPAC Novel-Payload Platform
August 28, 2026